NEW YORK (Reuters Health) - Overall, the use of drugs that reduce stomach acid, such as H2 blockers and proton pump inhibitors, do not increase the risk of cancer of the esophagus or stomach, according to a study reported in the journal Gut.>>> Discuss This Story
